Canaccord Genuity Reiterates a 'Hold' on XOMA, Ltd. (XOMA); Q1/11: Phase 3 Behcet's Q4/11, Phase 2 Cardiovascular 2012
Tweet Send to a Friend
Canaccord Genuity reiterates a 'Hold' on XOMA, Ltd. (NASDAQ: XOMA), PT $3.
Canaccord analyst says, "We see 052’s future in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst says, "We see 052’s future in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
